Colorectal Carcinoma Susceptibility and Metastases Are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms

Clinical Chemistry

Volumn 49, Issue 11, 2003, Pages 1940-1942

  Ghilardi, Giorgio ^a   Biondi, Maria Luisa ^b   Erario, Maddalena ^b   Guagnellini, Emma ^b   Scorza, Roberta ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; MATRILYSIN; STROMELYSIN;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; COLORECTAL CARCINOMA; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROMOTER REGION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES;

EID: 0242267933     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.018911     Document Type: Article

References (24)

1. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression therapeutical implications. Matrix Biol 1997;15:535-41.
2. Johnsen M, Lund LR, Romer J, Almholt K, Danø K. Cancer invasion and tissue remodeling common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998;10:667-71.
3. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000;18:1135-49.
4. Uría JA, Ståhle-Bäckdahl M, Seiki M, Fueyo A, López-Otín C. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interaction. Cancer Res 1997;57:4882-8.
5. Johansson N, Vaalamo MI, Grénman S, Hietanen S, Klemi P, Saarialho-Kere U, et al. Collagenase-3 (MMP13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 1999;154:469-80.
6. Skobe M, Fusening NE. Tumorigenic conversion of immortal human keratinocytes through small cell activation. Proc Natl Acad Sci USA 1998;95:1050-5.
7. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998;10:602-8.
8. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Exp 1996;6:391-411.
9. Wernert N, Gilles F, Faufer V, Bouali F, Raes MB, Pyke C, et al. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 1994;54:5683-8.
10. Rutter JL, Mitchell TI, Butticé G, Meyers J, Gusella JF, Ozelius LJ, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5.
11. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001;7:2344-6.
12. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-7.
13. Nishioka Y, Kobayashi K, Sagae S, Ishioka SI, Nishikawa A, Matsushima M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 2000;91:612-5.
14. Ye S, Dhillon S, Turner SJ, Bateman AC, Theaker JM, Pickering RM, et al. Invasiveness of cutaneous malignant melanoma is influenced by Matrix Metalloproteinase 1 gene polymorphism. Cancer Res 2001;61:1296-8.
15. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61:7825-9.
16. Ghilardi G, Biondi ML, Caputo M, Leviti S, De Monti M, Guagnellini E, et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 2002;8:3820-3.
17. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996;28:123-36.
18. Mori M, Barnard GF, Mimori K, Ueo H, Akiyoshi T, Sugimachi K. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 1995;75:1516-9.
19. Yamamoto H, Itoh F, Hinoda Y, Imai K. Suppression of matrilysin inhibits colon cancer invasion in vitro. Int J Cancer 1995;61:218-22.
20. Jormsjö S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2001;21:1834-9.
21. Chang AE. Colorectal cancer. In: Greenfield LI, ed. Surgery: scientific principles and practice. Philadelphia: JB Lippincott Co., 1993:1014-31.
22. Ichikawa Y, Ishikawa T, Momiyama N, Yamaguchi S, Masui H, Hasegawa S, et al. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin. Clin Exp Metastasis 1998;16:3-8.
23. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A, et al. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 2001;84:1317-21.
24. Newell KJ, Matrisian LM, Driman DK. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis dagger. Mol Carcinog 2002;34:59-63.